The medicine in the last years has been moving looking for a range of personalized treatments and based on the search for alternative methods of molecular and genetic analysis.
Marcela Moreno Wilches
Agencia Latina de Noticias Medicina y Salud Pública
In an interview with the Public Medicine and Health Review (MSP), the doctor Omayra Reyes, hematologist oncologist, discusses the benefit of anti-pd1 treatments in cancer and results in the importance and benefits of immunotherapy, which act estimating the immune system for combating the cell.
The specialist, qualifies these treatments as an advance in oncology medicine, giving the introduction of immunotherapies or the anti-pd1 he came to revolutionize oncology medicine in the sense that he was able to bring more years to life to patients who were previously treated with more limited treatments.
‘Basically in the case of immunotherapy, as its anti-pd1 agents have undergone a new combination with rhinoceros cancer patients, the cual has advanced, offering a sovereign enhanced comparison with that of basic treatment”Puntualizó la oncóloga.
Although comparing the drugs we have with the current ones, we can see that patients are offered a 24-month follow-up in 74 or 75% of patients.
The quality of life and the secondary effects, as well as many more manipulative ones, as well as the toxic effects observed in clinical studies, mean that in clinical practices it is observed that each has the highest number of patients treated. as they are treated with control inhibitors that basically allow to increase sobriety and maintain stable medical condition.
Treatments with inhibitors do not necessarily have to act in combination with other treatments, meaning that they can be used in a sequential form to reduce the likelihood of toxic effects.
Benefit of inhibiting anti-pd1
Compared to the treatments used over the years, the inhibitors of control measures contain a profile of secondary effects much more secure and the response that the patient obtains for his medical condition is much more sustainable.
Inside the treatment with this type of medication, Dr. Reyes also treats the tolerability that is related to the differences, a safe effect profile and above that the response profile that ofrecen, especially increasing the global sobriety of all patients lo utilizan.